Search results
Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting. Emend is used in patients aged from 6 months to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer).
What is Emend and what is it used for? Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting. Emend is used in patients aged from 6 months to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer). It is used with chemotherapy that is a moderate or strong trigger of nausea and vomiting.
Introduction. Emend is an oral substance P, aka human neurokinin 1 (NK-1)-receptor antagonist. Mammalian tachykinin substance P (SP) that binds to the NK-1 receptor has been associated with numerous inflammatory conditions, mediation of the emetic reflex and modulation of central nervous system disorders.
22 kwi 2024 · Expert Opinion. EMEND® 125 mg powder for oral suspension is the only licensed product containing aprepitant that is appropriate for paediatric patients under age 12. It has been reported that this product is in short supply in several of the member states in which it is licensed.
Co zawiera i jak działa Emend - kapsułki twarde? Zapobieganie nudnościom i wymiotom związanym z chemioterapią przeciwnowotworową o dużym i umiarkowanym ryzyku wymiotów u dorosłych i młodzieży w wieku od 12 lat. Preparat stosuje się w leczeniu skojarzonym.
2 wrz 2015 · Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has. approved a supplemental New Drug Application (sNDA) for EMEND ®. (aprepitant) capsules, a substance P/neurokinin 1 (NK1) receptor. antagonist.
EMEND is given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonist. The recommended dose is 125 mg orally once daily one hour before start of chemotherapy on Day 1 and 80 mg orally once daily on Days 2 and 3 in the morning.
